UiPath
PATH
10.96
-0.27
-2.40%
UiPath
US · PATH
#1806 by market cap
Listed 2021
10.96
-0.27
-2.40%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Company notice
Mynet: Hori越, CTO and Executive Officer at MyNet, will speak at the "Japan FinOps Community Gathering," where he will discuss the path toward embedding FinOps as an integral part of corporate culture.JPX · 2026/10/7
-
UiPath(PATH.US) 10% Shareholder Sells US$33.07 Million in Common StockMarket Newswire · 2026/10/20
-
Company notice
Itoki: Itohki Announces the Release of Its Integrated Report 2026, Outlining a Transformation into an AI Company Centered on People and Charting a Path to the Next Phase of Growth Toward Achieving Its Medium-Term Management Plan.JPX · 2026/9/30
-
Rating change
William Blair Maintains UiPath(PATH.US) With Hold RatingMarket Newswire · 2026/9/8
-
D.A. Davidson Downgrades UiPath(PATH.US) to Sell Rating, Cuts Target Price to $10Market Newswire · 2026/9/28
-
Company notice
PATH: Notice Regarding the Financial Results of Unlisted Parent Companies, etc.JPX · 2026/6/30
-
Rating change
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $14 to $17Market Newswire · 2026/9/25
-
Rating change
Citi Maintains UiPath(PATH.US) With Buy Rating, Maintains Target Price $23Market Newswire · 2026/9/9
-
Rating change
Oppenheimer Maintains UiPath(PATH.US) With Hold RatingMarket Newswire · 2026/9/4
-
Form 144 | UiPath(PATH.US) Director Proposes to Sell 32.65 Million in Common StocksMarket Newswire · 2026/10/16
-
Company notice
Green Earth Institute: From "research" to "mass production and commercialization": GEI outlines the path to industrialization, as presented at a business strategy briefing that also featured JAL.JPX · 2026/10/16
-
Company notice
PATH: Matters Concerning Controlling Shareholders, etc. (Fiscal Year Ending March 2026)JPX · 2026/7/23
-
Rating change
Morgan Stanley: Clear path to gross margin recovery; reaffirms "Overweight" rating on STMicroelectronics (STM.US)Zhitong Finance · 2026/10/30
-
RBC Capital Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $15Market Newswire · 2026/11/10
-
Rating change
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $14 to $22Market Newswire · 2026/9/24
-
Rating change
Citi Initiates UiPath(PATH.US) With Buy Rating, Announces Target Price $23Market Newswire · 2026/9/8
-
Rating change
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $15 to $19Market Newswire · 2026/9/5
-
Rating change
Barclays Maintains UiPath(PATH.US) With Hold Rating, Raises Target Price to $17Market Newswire · 2026/9/8
-
Rating change
BMO Capital Maintains UiPath(PATH.US) With Hold Rating, Raises Target Price to $18Market Newswire · 2026/9/4
-
UBS Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $14Market Newswire · 2026/9/26
-
Rating change
BofA Securities Initiates UiPath(PATH.US) With Sell Rating, Announces Target Price $15Market Newswire · 2026/9/4
-
U.S. Bancorp Earnings Call Signals Confident Growth PathTipRanks · 2026/10/16
-
The Average Maturity of U.S. Treasury Issuance Is Relatively Long: Debt Management Considerations Under the Path of Term Premium NormalizationCSOP · 2026/10/15
-
Medical Care Technologies Inc. (OTCID:MDCE) Outlines Path to Scale AI-Powered Software Revenue After $250,000 First AgreementACCESS Newswire · 2026/10/15
-
a16z Reviews the U.S. Crypto Industry’s Achievements Over the Past Three Years: Charting the Path ForwardJinse Finance · 2026/10/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.
UiPath discussion 0 comments